« Previous
Next »
The Spine Journal
Volume 9, Issue 12
, Pages 972-980
, December 2009
Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization
References
- . Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases. J Bone Joint Surg Am. 1993;75:1476–1484
- Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery. 1999;44:74–79discussion 79–80
- The surgical management of sacrococcygeal chordoma. Cancer. 1999;85:878–883
- Operative management of sacral chordoma. J Bone Joint Surg Am. 2005;87:2211–2216
- Oncologic and functional outcome following sacrectomy for sacral chordoma. J Bone Joint Surg Am. 2006;88:1532–1539
- Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88:2122–2134
- Clinical outcome in chordoma: utility of flow cytometry in DNA determination. Spine. 2002;27:374–379
- Chordoma of the spine above the sacrum. Treatment and outcome in 21 cases. Spine. 1996;21:1569–1577
- . Laparoscopically assisted radical sacrococcygectomy. A new operative approach to large sacrococcygeal chordomas. Surg Endosc. 1997;11:1118–1122
- Cephalad sacral resection with a combined extended ilioinguinal and posterior approach. J Bone Joint Surg Am. 1995;77:405–411
- . Total sacrectomy and reconstruction for huge sacral tumors. Spine. 1990;15:1223–1227
- . Surgical treatment of sacral tumors after transcatheter arterial embolization. Chinese J Orthop. 1998;18:646–648
- . Lumbosacral chordoma. Prognostic factors and treatment. Spine. 1999;24:1639–1645
- Surgical treatment of spinal chordomas. Arch Surg. 1987;122:1479–1482
- . Current management of sacral chordoma. Neurosurg Focus. 2003;15:E9
- . Clinicopathologic study of sacrococcygeal chordoma. Cancer. 1984;53:2574–2578
- Decision making in primary sacral tumors. Spine J. 2009;9:396–403
- . Vascular metastatic lesions of the spine: preoperative embolization. Radiology. 1990;176:683–686
- . Therapeutic percutaneous embolization for extra-axial vascular lesions of the head, neck, and spine. J Neurosurg. 1975;43:275–287
- Ablation of renal tumors with absolute ethanol: a new technique. Radiology. 1981;141:619–626
- Nuclear dynamics of PCNA in DNA replication and repair. Mol Cell Biol. 2005;25:9350–9359
- Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines. Int J Cancer. 1999;81:451–458
- Angiogenesis inhibitors overcome tumor induced endothelial cell anergy. Int J Cancer. 1999;80:315–319
- Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence. Neurosurgery. 2002;51:753–760
- Prognostic factors in chordoma: role of postoperative radiotherapy. Eur J Cancer. 1995;31A:2255–2259
- . Metastatic chordoma: pattern of spread and response to chemotherapy. Clin Oncol (R Coll Radiol). 1994;6:341–342
- Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg. 1993;78:741–747
- Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases. Cancer. 1994;74:2261–2267
- Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol. 2003;10:291–296
- . Sacrococcygeal chordoma: review of 50 consecutive patients. World J Surg. 1996;20:717–719
- Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol. 1996;41:67–72
- En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine. 2005;3:111–122
FDA device/drug status: not applicable.
Author disclosures: none.
PII: S1529-9430(09)00812-2
doi: 10.1016/j.spinee.2009.08.447
« Previous
Next »
The Spine Journal
Volume 9, Issue 12
, Pages 972-980
, December 2009
